NASDAQ · Medical - Pharmaceuticals

HITI (HITI) Stock

$2.12 -0.93% NASDAQ: HITI Healthcare

Valuation

MetricValue
Price$2.12
Market Cap$186.28M
P/E Ratio-3.87
P/B Ratio2.40
P/S Ratio0.46
EPS (TTM)$-0.62
52-Week High$4.05
52-Week Low$2.12
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-57.95%
ROA-14.61%
ROCE-13.59%
Gross Margin-2.36%
Operating Margin-2.36%
Net Margin-7.42%
Debt/Equity1.27
Current Ratio1.37

Annual Financials (USD)

Metric20212022202320242025
Revenue$181.0M$357.0M$488.0M$522.0M$594.0M
Operating Profit$-19.0M$-72.0M$-41.0M$5.0M$-14.0M
Net Profit$-34.0M$-72.0M$-39.0M$-4.0M$-51.0M
EPS$-0.83$-1.13$-0.53$-0.05$-0.62
Op Margin-10.3%-20.3%-8.5%1.0%-2.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$246.0M$275.0M$233.0M$246.0M$349.0M
Total Liabilities$94.0M$113.0M$100.0M$101.0M$246.0M
Cash$14.0M$25.0M$30.0M$47.0M$48.0M
Borrowings$55.0M$70.0M$73.0M$75.0M$150.0M

Latest News

Oil rises on intensifying US-Iran hostilities, threat of Red Sea closure Reuters · Jul 17, 2026 United Airlines stark warning could make your next flight more expensive TheStreet · Jul 17, 2026 CCTV+: Hello, Beijing! A City Alive with Performing Arts CNW Group · Jul 17, 2026 Exterro's ARMOURop Delivers a Force Multiplier for Digital Forensic Labs, Slashing Evidence Review Time by Up to 95% PR Newswire · Jul 17, 2026 Visa (V) Stock May Trade At A Discount To Fair Value Yet A Premium To Earnings Simply Wall St. · Jul 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$4.0M$21.0M$36.0M$24.0M
Investing Cash Flow$-39.0M$-18.0M$-12.0M$-21.0M$-33.0M
Financing Cash Flow$9.0M$-1.0M$0$0$0
Net Cash Flow$6.0M$11.0M$5.0M$17.0M$1.0M
Free Cash Flow$-14.0M$-5.0M$15.0M$26.0M$13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA31.30
FCF Yield6.51%
Quick Ratio0.72
Interest Coverage-1.08
Return 1Y-10.00%
Return 3Y68.75%
Return 5Y-66.41%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CVRX $4.88 +2.95% -2.98 $129.50M 0.00%
IMMPImmutep Limited $0.44 +0.90% -0.94 $64.36M 0.00%
LFMD $3.40 -7.61% -18.83 $164.43M 0.00%
OMIOwens & Minor, Inc. $2.68 +8.94% 14.39 $207.07M 0.00%
SENS $4.87 -0.81% -3.43 $203.54M 0.00%

About HITI

HITI is led by CEO Harkirat Grover, employs 1,750 people, headquartered in CA, publicly traded since 2021.

HITI stock trades at $2.12 with a market capitalization of $186.28M. The stock is valued at a price-to-earnings (P/E) ratio of -3.87, price-to-book of 2.40, price-to-sales of 0.46. Over the past 52 weeks the stock has ranged between $2.12 and $4.05, and currently trades 47.7% below its 52-week high.

On profitability, HITI generates a return on equity (ROE) of -57.95%, return on capital employed of -13.59%, an operating margin of -2.36%, a net profit margin of -7.42%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides